Home›Stock Screener›Indraprastha Medical Corporation›Financial Statements

Indraprastha Medical Corporation Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Indraprastha Medical Corporation (INDRAMEDCO) reported revenue ₹1,483 Cr, net profit ₹188 Cr and EPS ₹20.03, with a net profit margin of 12.7% and ROE of 25.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore INDRAMEDCO intrinsic value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 12.68% 2026 data
EBITDA Margin 18.00% 2026 data
Operating Margin 18.00% 2026 data
Return on Assets 18.97% 2026 data
Return on Equity 25.41% 2026 data

Balance Sheet Ratios

Current Ratio 5.15 2026 data
Equity Ratio 74.67% 2026 data
Asset Turnover 1.50 2026 data

INDRAMEDCO Revenue, Net Profit & EBITDA — Year-on-Year Growth

INDRAMEDCO YoY (March 2025 vs March 2026) — revenue +7.5%, net profit +16.8%, expenses +9.4%. For live price, earnings ratios and company overview, see INDRAMEDCO share price.

Revenue Growth
+7.5%
Year-over-Year
Net Profit Growth
+16.8%
Year-over-Year
Expense Growth
+9.4%
Year-over-Year
Assets Growth
+16.3%
Year-over-Year
Equity Growth
+24.0%
Year-over-Year
Operating Cash Flow Growth
-21.5%
Year-over-Year
Investing Cash Flow Growth
+29.7%
Year-over-Year
Financing Cash Flow Growth
-43.8%
Year-over-Year

INDRAMEDCO Income Statement — Revenue, EBITDA & Net Profit

Indraprastha Medical Corporation revenue ₹1,483 Cr, EBITDA ₹267 Cr, net profit ₹188 Cr, EPS ₹20.03 (2026) — net profit margin 12.7%. Review INDRAMEDCO earnings valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 1,483 1,379 1,262 1,109 891 614 832 789 754 766 758 715
Expenses 1,216 1,112 1,051 948 774 573 744 707 680 687 676 630
EBITDA 267 267 210 161 117 41 87 81 74 79 82 86
Operating Profit Margin % 18.00% 18.00% 16.00% 14.00% 13.00% 7.00% 10.00% 10.00% 10.00% 10.00% 11.00% 12.00%
Depreciation 44 44 40 39 35 33 33 30 31 31 35 28
Interest 6 6 4 4 3 3 6 7 9 8 7 8
Profit Before Tax 246 216 166 117 79 4 48 45 34 41 39 50
Tax 58 55 42 31 21 2 5 16 13 15 14 17
Net Profit 188 161 124 86 59 2 44 28 21 26 24 33
Earnings Per Share (₹) 20.03 17.56 13.52 9.40 6.39 0.25 4.76 3.10 2.30 2.86 2.67 3.54

INDRAMEDCO Balance Sheet — Assets, Liabilities & Shareholders' Equity

INDRAMEDCO total assets ₹991 Cr, total equity ₹740 Cr, total liabilities ₹ Cr (2026) — ROE 25.4%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 991 852 723 555 462 432 449 422 432 458 461 442
Current Assets 417 431 308 223 157 141 142 136 133 158 152 149
Fixed Assets 368 328 347 275 277 283 303 280 294 296 301 286
Capital Work in Progress 3 33 1 3 0 3 0 1 0 0 3 3
Investments 8 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 491 376 278 185 145 146 141 138 163 157 153
LIABILITIES
Total Liabilities
Current Liabilities 81 76 80 46 43 43 42 54 62 42 46 53
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 740 597 478 380 325 273 268 244 232 231 224 195
Share Capital 92 92 92 92 92 92 92 92 92 92 92 92
Reserves & Surplus 649 505 386 288 234 181 176 152 141 139 132 103

INDRAMEDCO Cash Flow Statement — Operating, Investing & Financing

Indraprastha Medical Corporation operating cash flow ₹157 Cr, investing ₹-111 Cr, financing ₹-46 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 157 200 145 94 27 86 75 48 28 62 64
Investing Activities -111 -158 -108 -74 -19 -40 -17 -30 -22 -33 -29
Financing Activities -46 -32 -26 -3 -3 -43 -44 -17 -5 -30 -35
Net Cash Flow 0 9 11 17 5 4 14 1 0 -1 0